Results 31 to 40 of about 862 (134)

Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver.

open access: yesJournal of Lipid Research, 1982
The neutral and acidic glycolipids from the liver of an 11-year-old male were quantitatively isolated and characterized. The total concentration of gangliosides was also determined in sampled from five other human livers.
O Nilsson, L Svennerholm
doaj   +1 more source

oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages. [PDF]

open access: yesPLoS ONE, 2016
Extravasation of macrophages and formation of lipid-laden foam cells are key events in the development and progression of atherosclerosis. The degradation of atherogenic lipoproteins subsequently leads to alterations in cellular lipid metabolism that ...
Stefan Wallner   +7 more
doaj   +1 more source

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy

open access: yesMolecular Therapy: Methods & Clinical Development, 2017
GM1 gangliosidosis is a fatal lysosomal disorder, for which there is no effective treatment. Adeno-associated virus (AAV) gene therapy in GM1 cats has resulted in a greater than 6-fold increase in lifespan, with many cats remaining alive at >5.7 years of
Heather L. Gray-Edwards   +9 more
doaj   +1 more source

Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma

open access: yesScientific Reports, 2020
Oncogenic drivers of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) such as c-MYC have downstream effects on intracellular metabolic pathways of clonal plasma cells (PCs).
Wilson I. Gonsalves   +8 more
doaj   +1 more source

Monoclonal antibody specific for lactosylceramide.

open access: yesJournal of Biological Chemistry, 1984
The mouse hybridoma line T5A7 was derived during studies aimed at mapping human myeloid differentiation antigens. The IgM antibody secreted by this line recognizes an antigen richly expressed on mature myelomonocytic cells and on a subpopulation of lectin-activated human T-lymphocytes (Andrews, R. G., Torok-Storb, B., and Bernstein, I. D.
F W, Symington   +2 more
openaire   +2 more sources

Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson’s disease

open access: yesJournal of Lipid Research
Alterations in sphingolipid metabolism have been implicated in the pathogenesis of Parkinson's disease (PD), yet findings regarding peripheral sphingolipid changes remain inconsistent.
Yu-Fong Peng   +4 more
doaj   +1 more source

Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids

open access: yesMovement Disorders, EarlyView.
Abstract Neurodegenerative diseases are pathological states characterized by progressive alterations in brain homeostasis during aging. Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are defined neuropathologically by the accumulation of inclusions known as Lewy bodies and Lewy neurites.
Manuel Flores‐León, Tiago F. Outeiro
wiley   +1 more source

Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease

open access: yesAdvanced Materials, Volume 38, Issue 17, 20 March 2026.
RNA interference (RNAi) nanomedicine revolutionizes treatment regimens for ischemic heart diseases by enabling tailored, sequence‐anchored gene regulation. This review highlights the recent advances in nanotechnology‐driven RNAi therapeutics for myocardial ischemia and discusses the key design principles that govern efficient delivery, providing ...
Han Gao, Da Pan, Hélder A. Santos
wiley   +1 more source

Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Although it has become clear that alterations in lipid metabolism are associated with Alzheimer's disease (AD), it is unclear how they contribute to both cognitive decline and the pathophysiology of AD. METHODS Lipidomics and activity‐based protein profiling (ABPP) were performed in the frontal cortex of control, AD and resilient ...
Daan van der Vliet   +12 more
wiley   +1 more source

Sphingolipids in Emotional Well‐Being

open access: yesJournal of Neurochemistry, Volume 170, Issue 2, February 2026.
Sphingolipids are essential constituents of neuronal membranes and are increasingly recognized as contributors to the key behavioral manifestations associated with emotional well‐being. ABSTRACT Emotional well‐being is a multifactorial concept, which comprises not only life quality of human individuals, but also their mental and physical health.
L. S. Kalinichenko   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy